<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>isfcppharmaspire</PublisherName>
      <JournalTitle>Pharmaspire</JournalTitle>
      <PISSN>C</PISSN>
      <EISSN>o</EISSN>
      <Volume-Issue/>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season/>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Pharmaceutics</ArticleType>
      <ArticleTitle>Nanocarrier Based Drug Delivery System – Future of Alzheimer Disease</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>0</FirstPage>
      <LastPage>0</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Jyoti</FirstName>
          <LastName>Sharma</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Alzheimer's disease has risen to the top most cause of mortality in the world. Every twenty years, the illness rate doubles, affecting about one in every 10 households. Alzheimer's disease is characterized by a gradual loss of neurons in the cerebral cortex, resulting in brain shrinkage. Senile neuritic plaques and neurofibrillary tangles become the disease's primary characteristic. However, a continuous strategy is customized to cure Alzheimer's disease effectively. However, as a result of difficulties in the medication delivery system induced by different barriers like BBB, CSF has become the primary cause of therapeutic failure. Thus, to address these problems, nanotechnology is a potential technique for overcoming them. This study discusses the use of targeted delivery of medicament for the successful remedy and diagnosis of Alzheimer's disease that utilizes nanocarriers as an alternative administration route, thus allowing the release of the drug into CNS.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Dementia,Alzheimer’s disease,Nanocarriers,Blood Brain Barrier,Targeted Drug Delivery</Keywords>
      <URLs>
        <Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=14512&amp;title=Nanocarrier Based Drug Delivery System – Future of Alzheimer Disease</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References/>
      </References>
    </Journal>
  </Article>
</ArticleSet>